Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Estrogen Receptor alpha | 19 | 2011 | 582 | 2.140 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 14 | 2016 | 164 | 1.760 |
Why?
|
Neoplasms, Hormone-Dependent | 14 | 2011 | 410 | 1.500 |
Why?
|
Receptors, Estrogen | 16 | 2017 | 2208 | 1.500 |
Why?
|
Receptors, Androgen | 15 | 2011 | 1077 | 1.260 |
Why?
|
Estrogens | 10 | 2010 | 1522 | 0.990 |
Why?
|
Response Elements | 5 | 2008 | 306 | 0.800 |
Why?
|
Gene Expression Regulation, Neoplastic | 19 | 2017 | 8531 | 0.770 |
Why?
|
Enhancer Elements, Genetic | 8 | 2011 | 1360 | 0.720 |
Why?
|
Mammary Neoplasms, Experimental | 3 | 2010 | 506 | 0.700 |
Why?
|
Chromatin Immunoprecipitation | 11 | 2009 | 848 | 0.680 |
Why?
|
Estradiol | 12 | 2016 | 1937 | 0.600 |
Why?
|
Breast Neoplasms | 30 | 2022 | 20982 | 0.570 |
Why?
|
Nuclear Receptor Coactivator 3 | 5 | 2010 | 46 | 0.570 |
Why?
|
Transcriptional Activation | 6 | 2009 | 1749 | 0.550 |
Why?
|
Tamoxifen | 6 | 2017 | 965 | 0.540 |
Why?
|
SOX9 Transcription Factor | 1 | 2017 | 145 | 0.540 |
Why?
|
Cell Line, Tumor | 37 | 2017 | 16954 | 0.510 |
Why?
|
Oligonucleotide Array Sequence Analysis | 12 | 2011 | 3777 | 0.500 |
Why?
|
Epidermal Growth Factor | 4 | 2016 | 699 | 0.490 |
Why?
|
RNA, Neoplasm | 2 | 2017 | 748 | 0.480 |
Why?
|
Transcription Factors | 17 | 2011 | 12101 | 0.480 |
Why?
|
Ribonucleoproteins | 1 | 2017 | 356 | 0.470 |
Why?
|
Antineoplastic Agents, Hormonal | 8 | 2017 | 1520 | 0.460 |
Why?
|
Transcription, Genetic | 11 | 2009 | 7571 | 0.460 |
Why?
|
Osteoclasts | 2 | 2008 | 711 | 0.450 |
Why?
|
Promoter Regions, Genetic | 15 | 2010 | 5773 | 0.410 |
Why?
|
RNA Splicing | 1 | 2017 | 896 | 0.410 |
Why?
|
Histone Acetyltransferases | 5 | 2008 | 335 | 0.390 |
Why?
|
Prostatic Neoplasms | 13 | 2017 | 11101 | 0.390 |
Why?
|
DNA Polymerase II | 3 | 2009 | 104 | 0.380 |
Why?
|
E2F1 Transcription Factor | 2 | 2010 | 178 | 0.370 |
Why?
|
Fas Ligand Protein | 2 | 2008 | 216 | 0.360 |
Why?
|
Protein-Arginine N-Methyltransferases | 2 | 2009 | 127 | 0.360 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2017 | 5301 | 0.350 |
Why?
|
Trans-Activators | 5 | 2010 | 2846 | 0.340 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1893 | 0.340 |
Why?
|
Gene Expression Regulation | 10 | 2009 | 11855 | 0.320 |
Why?
|
Cyclin D1 | 2 | 2009 | 451 | 0.310 |
Why?
|
Osteoblasts | 3 | 2008 | 1144 | 0.300 |
Why?
|
Oncogene Proteins | 3 | 2010 | 718 | 0.300 |
Why?
|
Neoplasm Proteins | 3 | 2018 | 3594 | 0.290 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2009 | 634 | 0.280 |
Why?
|
Breast | 3 | 2017 | 1964 | 0.280 |
Why?
|
GATA3 Transcription Factor | 1 | 2007 | 155 | 0.270 |
Why?
|
Androgens | 7 | 2011 | 1283 | 0.270 |
Why?
|
Chromosome Mapping | 4 | 2009 | 4612 | 0.260 |
Why?
|
Histones | 8 | 2011 | 2570 | 0.250 |
Why?
|
DNA-Binding Proteins | 9 | 2011 | 9567 | 0.250 |
Why?
|
Binding Sites | 11 | 2011 | 5988 | 0.250 |
Why?
|
Epigenesis, Genetic | 5 | 2010 | 3788 | 0.240 |
Why?
|
Nuclear Proteins | 5 | 2010 | 5783 | 0.230 |
Why?
|
Estrogen Receptor Modulators | 1 | 2003 | 58 | 0.220 |
Why?
|
Protein Kinases | 2 | 2010 | 1607 | 0.220 |
Why?
|
Chromosomes, Human | 1 | 2005 | 442 | 0.220 |
Why?
|
Models, Biological | 7 | 2010 | 9458 | 0.210 |
Why?
|
Chromatin | 7 | 2017 | 2946 | 0.210 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2010 | 926 | 0.210 |
Why?
|
Gene Expression Profiling | 13 | 2016 | 9417 | 0.200 |
Why?
|
Oncogenes | 2 | 2006 | 1220 | 0.200 |
Why?
|
Genome, Human | 6 | 2010 | 4423 | 0.200 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2002 | 131 | 0.190 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2003 | 221 | 0.190 |
Why?
|
Cell Proliferation | 9 | 2017 | 10423 | 0.190 |
Why?
|
Blotting, Western | 6 | 2011 | 5032 | 0.180 |
Why?
|
Gene Silencing | 6 | 2008 | 1495 | 0.180 |
Why?
|
Diet | 1 | 2018 | 8048 | 0.170 |
Why?
|
Repressor Proteins | 4 | 2008 | 2974 | 0.170 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12676 | 0.170 |
Why?
|
Endometrium | 1 | 2002 | 403 | 0.160 |
Why?
|
Tumor Cells, Cultured | 5 | 2009 | 6125 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 4567 | 0.160 |
Why?
|
Homeodomain Proteins | 4 | 2011 | 2414 | 0.150 |
Why?
|
Osteoporosis | 1 | 2008 | 1604 | 0.150 |
Why?
|
Receptors, Progesterone | 4 | 2011 | 1129 | 0.150 |
Why?
|
Protein Binding | 7 | 2009 | 9297 | 0.150 |
Why?
|
Carcinoma | 1 | 2009 | 2330 | 0.150 |
Why?
|
Humans | 71 | 2022 | 761222 | 0.140 |
Why?
|
Bone and Bones | 1 | 2008 | 2568 | 0.140 |
Why?
|
Nucleosomes | 2 | 2011 | 486 | 0.140 |
Why?
|
RNA Polymerase II | 3 | 2007 | 537 | 0.140 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2009 | 2871 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2010 | 987 | 0.130 |
Why?
|
Genomics | 2 | 2009 | 5829 | 0.130 |
Why?
|
Transfection | 6 | 2009 | 5748 | 0.130 |
Why?
|
Thyroid Neoplasms | 1 | 2009 | 2330 | 0.130 |
Why?
|
Cell Cycle | 4 | 2006 | 2926 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2010 | 2455 | 0.130 |
Why?
|
Models, Genetic | 6 | 2011 | 3430 | 0.120 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 561 | 0.120 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 2 | 2005 | 28 | 0.120 |
Why?
|
Adenocarcinoma | 3 | 2011 | 6341 | 0.120 |
Why?
|
Conserved Sequence | 2 | 2009 | 1162 | 0.120 |
Why?
|
Tissue Distribution | 3 | 2008 | 2263 | 0.110 |
Why?
|
Organ Specificity | 3 | 2010 | 1963 | 0.110 |
Why?
|
Dihydrotestosterone | 4 | 2011 | 195 | 0.110 |
Why?
|
Cytokines | 1 | 2008 | 7386 | 0.100 |
Why?
|
Receptor, erbB-2 | 3 | 2022 | 2553 | 0.100 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2002 | 1830 | 0.100 |
Why?
|
Nuclear Receptor Coactivator 2 | 2 | 2002 | 40 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 736 | 0.100 |
Why?
|
Acetyltransferases | 2 | 2004 | 231 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2002 | 2820 | 0.100 |
Why?
|
Cell Survival | 5 | 2008 | 5778 | 0.100 |
Why?
|
Mice, Transgenic | 4 | 2010 | 9520 | 0.100 |
Why?
|
Cell Line | 7 | 2011 | 15545 | 0.100 |
Why?
|
RNA, Small Interfering | 4 | 2010 | 3412 | 0.100 |
Why?
|
Organic Anion Transporters, Sodium-Independent | 1 | 2011 | 28 | 0.100 |
Why?
|
Mice | 13 | 2018 | 81330 | 0.090 |
Why?
|
Genetic Complementation Test | 2 | 2010 | 556 | 0.090 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2010 | 790 | 0.090 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2010 | 30 | 0.090 |
Why?
|
Organic Anion Transporters | 1 | 2011 | 101 | 0.090 |
Why?
|
Androgen Antagonists | 3 | 2011 | 1408 | 0.090 |
Why?
|
Mice, Knockout | 4 | 2010 | 14392 | 0.090 |
Why?
|
Signal Transduction | 10 | 2016 | 23419 | 0.090 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2009 | 38 | 0.080 |
Why?
|
Female | 25 | 2022 | 392552 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2010 | 504 | 0.080 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2009 | 81 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2011 | 1168 | 0.080 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2011 | 204 | 0.080 |
Why?
|
Orchiectomy | 1 | 2011 | 463 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2006 | 7851 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 475 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2002 | 4935 | 0.080 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 481 | 0.080 |
Why?
|
Methylation | 2 | 2009 | 1070 | 0.080 |
Why?
|
PAX2 Transcription Factor | 1 | 2008 | 86 | 0.080 |
Why?
|
Integrin alpha6 | 1 | 2008 | 30 | 0.080 |
Why?
|
Cell Division | 2 | 2009 | 4451 | 0.080 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 199 | 0.080 |
Why?
|
Tacrolimus Binding Proteins | 2 | 2010 | 193 | 0.080 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2010 | 452 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 318 | 0.080 |
Why?
|
Histone Demethylases | 1 | 2011 | 322 | 0.080 |
Why?
|
Genes, erbB-2 | 1 | 2008 | 162 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2009 | 193 | 0.080 |
Why?
|
Epigenomics | 2 | 2011 | 944 | 0.080 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2010 | 316 | 0.070 |
Why?
|
Progestins | 1 | 2010 | 301 | 0.070 |
Why?
|
Animals | 14 | 2018 | 168089 | 0.070 |
Why?
|
Ovariectomy | 1 | 2010 | 614 | 0.070 |
Why?
|
Glucuronosyltransferase | 1 | 2008 | 132 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2009 | 5871 | 0.070 |
Why?
|
Cell Differentiation | 4 | 2011 | 11512 | 0.070 |
Why?
|
Luciferases | 2 | 2009 | 710 | 0.070 |
Why?
|
Tissue Array Analysis | 1 | 2009 | 550 | 0.070 |
Why?
|
Estrogen Receptor beta | 1 | 2008 | 169 | 0.070 |
Why?
|
Lipids | 1 | 2018 | 3331 | 0.070 |
Why?
|
Proteins | 1 | 2002 | 5993 | 0.070 |
Why?
|
Insulin | 1 | 2002 | 6588 | 0.070 |
Why?
|
Histone Code | 1 | 2008 | 158 | 0.070 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2011 | 1146 | 0.070 |
Why?
|
Software | 3 | 2011 | 4431 | 0.070 |
Why?
|
NFI Transcription Factors | 1 | 2006 | 42 | 0.070 |
Why?
|
Immunohistochemistry | 3 | 2011 | 11067 | 0.070 |
Why?
|
RNA, Messenger | 6 | 2010 | 12747 | 0.070 |
Why?
|
3T3 Cells | 1 | 2008 | 1083 | 0.070 |
Why?
|
Genome | 3 | 2010 | 1738 | 0.070 |
Why?
|
Transcription Initiation Site | 1 | 2006 | 187 | 0.070 |
Why?
|
Immunoblotting | 2 | 2009 | 1644 | 0.060 |
Why?
|
Cell Movement | 4 | 2010 | 5195 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2006 | 2897 | 0.060 |
Why?
|
Neoplasms, Basal Cell | 1 | 2006 | 31 | 0.060 |
Why?
|
beta Catenin | 1 | 2011 | 1042 | 0.060 |
Why?
|
Endometrial Hyperplasia | 1 | 2006 | 97 | 0.060 |
Why?
|
Down-Regulation | 3 | 2009 | 2916 | 0.060 |
Why?
|
Ligands | 2 | 2003 | 3264 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2004 | 1933 | 0.060 |
Why?
|
G1 Phase | 1 | 2006 | 404 | 0.060 |
Why?
|
Alkaline Phosphatase | 1 | 2008 | 859 | 0.060 |
Why?
|
Nuclear Receptor Co-Repressor 2 | 1 | 2005 | 33 | 0.060 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2005 | 227 | 0.060 |
Why?
|
Oligonucleotides | 1 | 2008 | 563 | 0.060 |
Why?
|
Gene Dosage | 1 | 2009 | 1217 | 0.060 |
Why?
|
Epithelial Cells | 3 | 2010 | 3671 | 0.060 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2005 | 346 | 0.060 |
Why?
|
Receptors, CXCR4 | 1 | 2009 | 727 | 0.060 |
Why?
|
Neurons | 2 | 2011 | 9429 | 0.060 |
Why?
|
beta-Naphthoflavone | 1 | 2003 | 5 | 0.060 |
Why?
|
Estrogen Antagonists | 1 | 2004 | 150 | 0.060 |
Why?
|
Enzyme Activation | 1 | 2010 | 3577 | 0.060 |
Why?
|
beta-Galactosidase | 1 | 2005 | 574 | 0.060 |
Why?
|
Coculture Techniques | 1 | 2008 | 1334 | 0.060 |
Why?
|
Chromosomes, Human, X | 1 | 2006 | 320 | 0.060 |
Why?
|
Molecular Sequence Data | 5 | 2010 | 17598 | 0.060 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2003 | 89 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10756 | 0.060 |
Why?
|
RNA Interference | 3 | 2009 | 2816 | 0.060 |
Why?
|
Microarray Analysis | 1 | 2006 | 748 | 0.050 |
Why?
|
MicroRNAs | 2 | 2009 | 3758 | 0.050 |
Why?
|
DNA, Neoplasm | 1 | 2008 | 1743 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2009 | 2509 | 0.050 |
Why?
|
Mammary Glands, Animal | 1 | 2004 | 272 | 0.050 |
Why?
|
Algorithms | 3 | 2008 | 14025 | 0.050 |
Why?
|
Male | 17 | 2017 | 360703 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4642 | 0.050 |
Why?
|
Liver | 1 | 2018 | 7512 | 0.050 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2004 | 412 | 0.050 |
Why?
|
Mice, Inbred C57BL | 3 | 2011 | 22128 | 0.050 |
Why?
|
Apoptosis | 2 | 2009 | 9478 | 0.050 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 2002 | 42 | 0.050 |
Why?
|
Gene Expression | 4 | 2009 | 7571 | 0.050 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2005 | 422 | 0.050 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2002 | 60 | 0.050 |
Why?
|
Intestines | 1 | 2010 | 1908 | 0.050 |
Why?
|
Aromatase | 1 | 2002 | 147 | 0.050 |
Why?
|
Colonic Neoplasms | 2 | 2010 | 2527 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2006 | 1130 | 0.050 |
Why?
|
Genes, myc | 1 | 2002 | 390 | 0.050 |
Why?
|
Gene Regulatory Networks | 1 | 2009 | 1743 | 0.040 |
Why?
|
Endopeptidases | 1 | 2004 | 766 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2022 | 9025 | 0.040 |
Why?
|
Cell Line, Transformed | 1 | 2002 | 864 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2006 | 4167 | 0.040 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2008 | 1605 | 0.040 |
Why?
|
Caco-2 Cells | 2 | 2010 | 363 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 2006 | 982 | 0.040 |
Why?
|
Cell Lineage | 1 | 2009 | 2549 | 0.040 |
Why?
|
Sirolimus | 1 | 2006 | 1540 | 0.040 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1429 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3596 | 0.040 |
Why?
|
NF-kappa B | 1 | 2008 | 2475 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2006 | 1767 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2010 | 3031 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13632 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2008 | 6200 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2022 | 697 | 0.040 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2008 | 1074 | 0.040 |
Why?
|
Base Sequence | 4 | 2010 | 12404 | 0.040 |
Why?
|
Cell Growth Processes | 2 | 2009 | 382 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2022 | 559 | 0.040 |
Why?
|
In Situ Hybridization | 1 | 2002 | 1900 | 0.040 |
Why?
|
DNA | 2 | 2008 | 7189 | 0.040 |
Why?
|
Homeostasis | 1 | 2009 | 3322 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2006 | 2058 | 0.040 |
Why?
|
Antigens, CD | 1 | 2008 | 4009 | 0.040 |
Why?
|
Histone Deacetylases | 1 | 2002 | 717 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2002 | 1057 | 0.040 |
Why?
|
Prostate | 1 | 2005 | 1772 | 0.040 |
Why?
|
Dioxygenases | 2 | 2009 | 346 | 0.030 |
Why?
|
Serpins | 1 | 2018 | 247 | 0.030 |
Why?
|
Telomerase | 1 | 2002 | 741 | 0.030 |
Why?
|
Transcription Factor AP-2 | 1 | 2016 | 78 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 12940 | 0.030 |
Why?
|
Enzyme Inhibitors | 2 | 2003 | 3702 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2005 | 2465 | 0.030 |
Why?
|
Indoles | 1 | 2003 | 1830 | 0.030 |
Why?
|
Bone Density | 1 | 2008 | 3546 | 0.030 |
Why?
|
Polymorphism, Genetic | 2 | 2002 | 4243 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2006 | 3571 | 0.030 |
Why?
|
Biological Transport | 2 | 2011 | 2081 | 0.030 |
Why?
|
Protein Isoforms | 2 | 2010 | 1695 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2006 | 4190 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3726 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6819 | 0.030 |
Why?
|
Nitriles | 2 | 2009 | 971 | 0.030 |
Why?
|
HeLa Cells | 2 | 2009 | 3073 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2002 | 2444 | 0.030 |
Why?
|
Endometrial Neoplasms | 1 | 2002 | 1366 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 1089 | 0.030 |
Why?
|
Cohort Studies | 3 | 2010 | 41496 | 0.020 |
Why?
|
Incidence | 1 | 2010 | 21366 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15920 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2002 | 2803 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2018 | 1783 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2006 | 18927 | 0.020 |
Why?
|
GATA6 Transcription Factor | 1 | 2010 | 50 | 0.020 |
Why?
|
Cell Adhesion | 2 | 2008 | 3091 | 0.020 |
Why?
|
Promegestone | 1 | 2010 | 9 | 0.020 |
Why?
|
Octamer Transcription Factor-1 | 1 | 2010 | 30 | 0.020 |
Why?
|
Plicamycin | 1 | 2010 | 12 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 13402 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2010 | 127 | 0.020 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2011 | 241 | 0.020 |
Why?
|
GA-Binding Protein Transcription Factor | 1 | 2009 | 43 | 0.020 |
Why?
|
Angiomyolipoma | 1 | 2011 | 188 | 0.020 |
Why?
|
Serum Response Factor | 1 | 2009 | 78 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2002 | 4513 | 0.020 |
Why?
|
Cell Nucleus | 2 | 2010 | 2881 | 0.020 |
Why?
|
Neoplasm Metastasis | 2 | 2010 | 4909 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 471 | 0.020 |
Why?
|
Tosyl Compounds | 1 | 2009 | 115 | 0.020 |
Why?
|
E2F Transcription Factors | 1 | 2009 | 269 | 0.020 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 2009 | 109 | 0.020 |
Why?
|
Arabidopsis Proteins | 1 | 2010 | 264 | 0.020 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2009 | 182 | 0.020 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 501 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2009 | 739 | 0.020 |
Why?
|
Melanocytes | 1 | 2011 | 509 | 0.020 |
Why?
|
Propionates | 1 | 2008 | 181 | 0.020 |
Why?
|
Phosphorylcholine | 1 | 2008 | 153 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2011 | 58952 | 0.020 |
Why?
|
Androgen Receptor Antagonists | 1 | 2008 | 125 | 0.020 |
Why?
|
Ribonuclease III | 1 | 2009 | 267 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2008 | 294 | 0.020 |
Why?
|
Chemokine CXCL12 | 1 | 2009 | 454 | 0.020 |
Why?
|
Postmenopause | 1 | 2016 | 2514 | 0.020 |
Why?
|
Mammary Glands, Human | 1 | 2008 | 202 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2011 | 13386 | 0.020 |
Why?
|
Anoikis | 1 | 2006 | 50 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2010 | 720 | 0.020 |
Why?
|
Retinoblastoma Protein | 1 | 2010 | 671 | 0.020 |
Why?
|
Anilides | 1 | 2009 | 411 | 0.020 |
Why?
|
Isoenzymes | 1 | 2010 | 1682 | 0.020 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 855 | 0.020 |
Why?
|
Uniparental Disomy | 1 | 2006 | 45 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1602 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2010 | 1518 | 0.020 |
Why?
|
Genes, X-Linked | 1 | 2006 | 127 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3875 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2006 | 286 | 0.020 |
Why?
|
Sweden | 1 | 2008 | 1379 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2010 | 1240 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2008 | 1989 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2011 | 1488 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2018 | 4574 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2006 | 418 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 2009 | 754 | 0.010 |
Why?
|
Phenols | 1 | 2008 | 517 | 0.010 |
Why?
|
DNA Methylation | 2 | 2011 | 4384 | 0.010 |
Why?
|
Area Under Curve | 1 | 2008 | 1636 | 0.010 |
Why?
|
Phenotype | 1 | 2002 | 16575 | 0.010 |
Why?
|
Boronic Acids | 1 | 2008 | 915 | 0.010 |
Why?
|
Drug Synergism | 1 | 2008 | 1756 | 0.010 |
Why?
|
Middle Aged | 4 | 2016 | 220858 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2010 | 1480 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2658 | 0.010 |
Why?
|
Time Factors | 1 | 2005 | 39957 | 0.010 |
Why?
|
Tuberous Sclerosis | 1 | 2011 | 1031 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2008 | 1022 | 0.010 |
Why?
|
Alleles | 2 | 2006 | 6857 | 0.010 |
Why?
|
Disease Progression | 2 | 2011 | 13511 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4107 | 0.010 |
Why?
|
Genotype | 2 | 2011 | 12985 | 0.010 |
Why?
|
Pregnancy | 1 | 2004 | 29893 | 0.010 |
Why?
|
RNA, Untranslated | 1 | 2006 | 453 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2009 | 1301 | 0.010 |
Why?
|
Keratinocytes | 1 | 2006 | 790 | 0.010 |
Why?
|
Pyrazines | 1 | 2008 | 1202 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2009 | 1662 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2016 | 12341 | 0.010 |
Why?
|
Mice, Nude | 1 | 2008 | 3606 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4111 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9187 | 0.010 |
Why?
|
CpG Islands | 1 | 2006 | 1190 | 0.010 |
Why?
|
Genetic Loci | 1 | 2010 | 2623 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6486 | 0.010 |
Why?
|
Testosterone | 1 | 2011 | 2472 | 0.010 |
Why?
|
Aged | 2 | 2011 | 169292 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8300 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3590 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2002 | 781 | 0.010 |
Why?
|
Adult | 3 | 2011 | 221120 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2381 | 0.010 |
Why?
|
BRCA1 Protein | 1 | 2006 | 1149 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18222 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6067 | 0.010 |
Why?
|
Health Surveys | 1 | 2008 | 4037 | 0.010 |
Why?
|
Pyrazoles | 1 | 2008 | 2010 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3446 | 0.010 |
Why?
|
Hormone Replacement Therapy | 1 | 2002 | 751 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2003 | 64681 | 0.010 |
Why?
|
Brachytherapy | 1 | 2002 | 1223 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2002 | 2913 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4251 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4851 | 0.010 |
Why?
|
Prostatectomy | 1 | 2002 | 1825 | 0.010 |
Why?
|
Internet | 1 | 2006 | 3096 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2002 | 22174 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2002 | 2426 | 0.010 |
Why?
|
Regression Analysis | 1 | 2002 | 6345 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2009 | 9278 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2002 | 8519 | 0.010 |
Why?
|
Physicians | 1 | 2008 | 4584 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 8002 | 0.010 |
Why?
|
Risk Factors | 2 | 2010 | 74241 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 29688 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2002 | 11119 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 11733 | 0.000 |
Why?
|
Quality of Life | 1 | 2002 | 13367 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2002 | 17897 | 0.000 |
Why?
|
Prospective Studies | 1 | 2002 | 54437 | 0.000 |
Why?
|